Brigit Biofarmaka Teknologi Tbk. vs Unilever Indonesia Tbk. — how do they compare? Brigit Biofarmaka Teknologi Tbk. trades at Rp254 (market cap 172.82B, 592.2K 24h volume), while Unilever Indonesia Tbk. trades at Rp1,710 (market cap 66.19T, 17.49M 24h volume). The key difference: Unilever Indonesia Tbk. is far larger — about 383× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Unilever Indonesia Tbk. is more actively traded (17.49M versus 592.2K). Which is the better fit depends on your goals.
| OBAT | UNVR | |
|---|---|---|
Market Cap | 172.82B | 66.19T |
Volume | 592.2K | 17.49M |
Lot | 5.92K | 174.92K |
Turnover | 147.05M | 30.1B |
Average Price | 248.31 | 1,720.92 |
Value | 147.05M | 30.1B |
Indicative Equilibrium Price | 254 | 1,710 |
Indicative Equilibrium Volume | 10 | 13.43K |
Trailing returns across standard periods
Latest headlines on both assets
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →PT Unilever Indonesia Tbk (the Company) was established on 5 December 1933 as Levers Zeepfabrieken N.V. by deed No. 23 of Mr. A.H. van Ophuijsen, a notary in Batavia, which was approved by the Gouverneur Generaal van Nederlandsch-Indie in letter No. 14 on 16 December 1933, registered at the Raad van Justitie in Batavia under No. 302 on 22 December 1933 and published in the Javasche Courant on 9 January 1934, Supplement No. 3.
Read more on UNVR →